HCM
AGN

Highbridge Capital Management’s Allergan plc AGN Stock Holding History

Highbridge Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,900
Closed -$319K – 1466
2018
Q1 		$319K Sell
1,900
-8,300
-81% -$1.39M 0.01% 851
2017
Q4 		$1.67M Buy
+10,200
New +$1.83M 0.03% 429
2015
Q2 		– Sell
-13,500
Closed -$4.02M – 1779
2015
Q1 		$4.02M Buy
+13,500
New +$3.85M 0.06% 362
2014
Q1 		– Sell
-2,000
Closed -$337K – 1321
2013
Q4 		$337K Buy
+2,000
New +$313K ﹤0.01% 797

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Highbridge Capital Management's AGN Position: Q4 2018 in Review

Highbridge Capital Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 14,055 shares — an estimated $2.68M sold.

Highbridge Capital Management first reported a position in AGN in Q2 2013 and held it in 15 quarters. The position peaked at $43.5M in Q3 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Highbridge Capital Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 14,055 Allergan plc shares in Q4 2018, an estimated $2.68M.
  • Highbridge Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 15 quarters.
  • Highbridge Capital Management's Allergan plc position peaked at $43.5M in Q3 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.